Found 16 matching trials
Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer PHASE1 This is a phase I, open-label trial to evaluate the safety and immunogenici...
Show More Location
Chesapeake Urology Research Associates
Learn More & Join Trial
Therapeutic Vaccination in Treated HIV Disease PHASE1 The central premise of our program is that durable control of HIV in the ab...
Show More Location
University of California, Los Angeles
Learn More & Join Trial
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer PHASE2 The aim of this study is to assess the potential benefit of the addition of...
Show More Location
Centre Hospitalier Universitaire Vaudois
Learn More & Join Trial
GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC PHASE1 This is a single-arm, open-label, multi-site Phase I/IIa study of a persona...
Show More Status
Active Not Recruiting
Location
Johns Hopkins Hospital
Learn More & Join Trial
INO 5401 Vaccination in BRCA1/2 Mutation Carriers PHASE1 The research study is being conducted to test an experimental vaccine to po...
Show More Status
Active Not Recruiting
Location
University of Pennsylvania
Learn More & Join Trial
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers PHASE2 This phase II trial studies how well deoxyribonucleic acid (DNA) plasmid-en...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma PHASE1 This is a Phase I/IIA, open-label, multi-center trial to evaluate the safet...
Show More Location
Mayo Clinic Cancer Center
Learn More & Join Trial
Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers PHASE1 This study evaluates whether INO-4212 and its components INO-4201 and INO-4...
Show More Learn More & Join Trial
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) PHASE1 Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies PHASE1 This is a Phase I, open-label study to evaluate the safety, tolerability, a...
Show More Location
University of Pennsylvania
Learn More & Join Trial